| 產品詳情 |
| Edit |   |
|---|
| Product Name | Troglitazone |
|---|
| Description | Selective PPARγ receptor agonist (EC50 values are 780 and 555 nM at murine and human PPARγ receptors respectively). Displays no activity at PPARα or PPARδ receptors. Antidiabetic agent; exerts potent glucose-lowering effects in insulin-resistant diabetic mice. Displays anti-invasive effect on human breast cancer cells; reduces migration, adhesion and spreading on fibronectin-coated plates. Also inhibits cell growth of hematopoietic cell lines. Inhibits lamellipodia formation and actin polymerization. Purity 97%. MW (observed): 441.54 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione. Rezulin |
|---|
| Gene, Accession, CAS # | CAS: 97322-87-7 |
|---|
| Catalog # | 3114/10 |
|---|
| Price | |
|---|
| Order / More Info | Troglitazone from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25917103, 26589882, 28625738 |
|---|
| 產品資料 |
|
|